αααααβααΎαILMN β’ NASDAQ
add
Illumina Inc
127.74$
αααααααααα(0.016%)-0.020
127.72$
ααΆααα·αα 6 ααααΆ, 4:28:26 PM ααααβααα -4 · USD · NASDAQ · ααα
ααααΈαααααΆααα·αααα½ααα»αααααΌα
ααΆαβα αα»αααΌααααααααααΆαα
α»ααααααΈαα
α’αΆαααα·αααΆαααΈααααΆααααΆααααααΆααα
α’αΆαααα·α
αα·αααΈαα»α
127.38$
α
αααααααααααα
126.48$ - 128.72$
α
ααααααα½αααααΆαα
α»αααααα
68.70$ - 155.47$
ααΎαβαα»αβααΈααααΆα
19.53Β αααΈααΆα USD
ααα ααα½αααΌαααααα
1.72Β ααΆα
α’αα»ααΆα P/E
23.44
αα·αααααβααΆαααΆα
-
ααΆααααααΌαα
αααα
NASDAQ
ααααααΆαααΈααααΆα
.INX
0.44%
0.36%
α α·ααααααααα»
αααΆαααΆαααααααΆααα
αααΌα
α
αααΌα
α
αααΌααα»ααα
| (USD) | ααααΌ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌα | 1.16Β αααΈααΆα | 4.98% |
α
αααΆαααααα·ααααα·ααΆα | 549.00Β ααΆα | 11.13% |
α
αααΌααα»ααα | 334.00Β ααΆα | 78.61% |
ααααΆααα
αααααα»ααα | 28.82 | 70.13% |
βα
αααΌααα»αααβαααα»ααα½αααΆαα αα»α | 1.35 | 56.98% |
α
αααΌααα»ααααα»αααΆαααααΆαα αααα ααΆαααααα αα·αααΆαααΆααααααα | 294.00Β ααΆα | -8.70% |
α’ααααΆαααααααααΆαααααα·αααααΆα | 11.41% | β |
αααααΈαααα»ααα
ααααααααα»α
ααΆαααα½ααα»αααααΌαααα»α
| (USD) | ααααΌ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
ααΆα
αααααΆαα αα·αααΆααα·αα·αααααααααααααΈ | 1.63Β αααΈααΆα | 33.85% |
ααααααααα»α | 6.64Β αααΈααΆα | 5.41% |
ααΆαααα½ααα»αααααΌαααα»α | 3.92Β αααΈααΆα | -0.23% |
ααΌαβααααα»α | 2.72Β αααΈααΆα | β |
ααΆαα αα»αβαα·αβααΆααααΆαααα | 152.90Β ααΆα | β |
ααααααααααΉαααααα
| 7.16 | β |
ααα
ααααααΎαααααα | 8.89% | β |
ααα
ααααααΎααΎααα»α | 11.14% | β |
ααα αΌαβααΆα
αβααααΆααβ
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα
| (USD) | ααααΌ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌααα»ααα | 334.00Β ααΆα | 78.61% |
ααΆα
αααααΆααααΈααααα·ααααα·ααΆα | 321.00Β ααΆα | -11.81% |
ααΆα
αααααΆααααΈααΆααα·αα·ααα | 108.00Β ααΆα | 325.00% |
ααΆα
αααααΆααααΈα α·ααααβαααααΆα | -63.00Β ααΆα | -34.04% |
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα | 368.00Β ααΆα | 42.64% |
ααα αΌαααΆα
αααααΆααααααα | 184.25Β ααΆα | -22.67% |
α’αααΈ
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.
Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies. Wikipedia
ααΆααααααΎαα‘αΎα
1998
ααΆαα·ααΆαααβαααααΆα
αααααβαααααΆα
αα»ααααα·α
8,625